Premas Biotech is an entrepreneurial biotechnology venture based on knowledge delivery and technology development in the biotech arena
Formed on the motto of "Partners in Discovery", Premas Biotech is an entrepreneurial biotechnology venture that has been founded by a group of talented scientific experts and experienced sales and marketing professionals with in-depth as well as wide knowledge of both technical as well as market dynamics.
They have been associated or served with institutes, companies and multinationals like The Scripps Research Institute (USA), University of Cambridge (UK), IIT-Bombay (India), Novartis (Switzerland), Naval Research Lab (Washington D.C, USA) Abbott Molecular diagnostics, Illumina (USA), Genomic Solutions (UK), Bio-Rad (USA), Ranbaxy (India) and Xerox (India) .
They have had comprehensive understanding of scientific and market dynamics; and have served or associated with internationally reputed organizations.
Premas Biotech's foundations are based on knowledge delivery and technology development in the biotech arena, support, consultancy, design and validation of the drug discovery and related processes.
The three main operational activities/functions Premas Biotech will undertake are Contract Research Services; Consultancy; and Business Development in Life sciences research as well as Molecular Diagnostics.
Contract Research Services will initially be focused on Assay Development, Novel Diagnostic Technologies and Bioinformatics.
Consultancy Services will be focused on Drug Discovery, Scale Up and Validation.
Business Development will focus on sales and marketing of Life Sciences as well as Molecular diagnostics products from reputed companies and principals.
Premas Biotech will have a "state of the art" lab facility envisaged to be set up in Manesar.
The employees will comprise mostly of PhDs in the biotech area with considerable experience and expertise.
Being knowledge intensive the lab processes will consume natural resources.
The processes and outputs are non-polluting and have emissions which are lower than that of sewage.
The team expertise will deliver drug discovery related solutions to prospective national as well as international business partners.
